The appearance of this RB1 mutation coincided with loss of adenocarcinoma features, including PSA expression (compare Fig. 4b, top and middle panels, to Fig. 1a), and gain of neuroendocrine features in the tumor, which was confirmed by synaptophysin expression (Fig. 4b, bottom panel). Here, RB1 is linked to adenocarcinoma.